World's Best Scientists 2026 revealed!
Kazuo Mishima

Kazuo Mishima

D-Index & Metrics

Neuroscience

D-Index
48
Citations
9082
World Ranking
6179
National Ranking
199

Overview

Kazuo Mishima is affiliated with Akita University in Japan and has contributed extensively to research in medicine, psychology, and neuroscience. Their work spans over 105 publications in medicine, 76 in psychology, and 57 in neuroscience, reflecting a broad engagement with health and cognitive sciences.

Their research predominantly covers subfields such as experimental and cognitive psychology, cognitive neuroscience, and psychiatry and mental health. Other areas of specialization include education and endocrine and autonomic systems research. Mishima's main topics of interest include sleep and related disorders, sleep and wakefulness research, and youth substance use and school attendance. Additionally, they have contributed to studies on schizophrenia research and treatment, circadian rhythm and melatonin, electroconvulsive therapy studies, and sleep and work-related fatigue.

Frequent publication venues for Mishima's work include Neuropsychopharmacology Reports and Scientific Reports, each with eight publications. Other significant outlets are Frontiers in Psychiatry, BMC Psychiatry, and Psychiatry and Clinical Neurosciences. These venues underline a consistent presence in psychiatric and neuroscientific academic journals.

Mishima has collaborated regularly with several co-authors notable for multiple joint publications. These include Masahiro Takeshima, Ken Inada, Naoko Ayabe, Masaya Ogasawara, and Yu Itoh. These collaborations indicate ongoing research partnerships within their academic network.

The scientist has contributed to numerous papers, including:

  • Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials, 2020, Molecular Psychiatry
  • Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis, 2020, Molecular Psychiatry
  • Cross-sectional survey of depressive symptoms and suicide-related ideation at a Japanese national university during the COVID-19 stay-home order, 2021, Environmental Health and Preventive Medicine
  • Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020, 2022, Respiratory Investigation
  • Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders, 2020, BMC Psychiatry

Best Publications

  • Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome

    Takashi Ebisawa;Makoto Uchiyama;Naofumi Kajimura;Kazuo Mishima

  • Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia

    K. Mishima;M. Okawa;Y. Hishikawa;S. Hozumi

  • Diminished melatonin secretion in the elderly caused by insufficient environmental illumination.

    K. Mishima;M. Okawa;T. Shimizu;Y. Hishikawa

  • Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep–waking

    Kazuo Mishima;Tozawa Tozawa;Kohtoku Satoh;Yasuhiro Matsumoto

  • EVENING PREFERENCE IS RELATED TO THE INCIDENCE OF DEPRESSIVE STATES INDEPENDENT OF SLEEP-WAKE CONDITIONS

    Shingo Kitamura;Akiko Hida;Makiko Watanabe;Minori Enomoto

  • The 3111T/C polymorphism of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample.

    Kazuo Mishima;Takuma Tozawa;Kohtoku Satoh;Hidetomo Saitoh

  • Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment.

    M Okawa;K Mishima;Y Hishikawa;S Hozumi

  • Sleep debt elicits negative emotional reaction through diminished amygdala-anterior cingulate functional connectivity.

    Yuki Motomura;Shingo Kitamura;Kentaro Oba;Yuri Terasawa

  • Human blood metabolite timetable indicates internal body time

    Takeya Kasukawa;Masahiro Sugimoto;Masahiro Sugimoto;Akiko Hida;Yoichi Minami

  • Mutation screening of the human Clock gene in circadian rhythm sleep disorders.

    Toshio Iwase;Naofumi Kajimura;Makoto Uchiyama;Takashi Ebisawa

  • Validity of the Japanese version of the Munich ChronoType Questionnaire

    Shingo Kitamura;Akiko Hida;Sayaka Aritake;Shigekazu Higuchi

  • Vitamin B12 Treatment for Sleep-Wake Rhythm Disorders

    M Okawa;K Mishima;T Nanami;T Shimizu

  • A missense variation in human Casein kinase I Epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders

    Atsuko Takano;Makoto Uchiyama;Naofumi Kajimura;Kazuo Mishima

  • Randomized, DIM Light Controlled, Crossover test of Morning Bright Light Therapy for Rest-Activity Rhythm Disorders in Patients with Vascular Dementia and Dementia of Alzheimer's type

    Kazuo Mishima;Yasuo Hishikawa;Masako Okawa

  • Differential Response of Period 1 Expression within the Suprachiasmatic Nucleus

    Wataru Nakamura;Shin Yamazaki;Shin Yamazaki;Nana N. Takasu;Nana N. Takasu;Kazuo Mishima;Kazuo Mishima

  • Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.

    Taro Kishi;Toshikazu Ikuta;Yuki Matsuda;Kenji Sakuma

  • Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons.

    K. Mishima;M. Okawa;S. Hozumi;Y. Hishikawa

  • Molecular and immunological characterization of ADP-ribosylarginine hydrolases.

    J. Moss;S. J. Stanley;M. S. Nightingale;J. J. Murtagh

  • Screening of Clock Gene Polymorphisms Demonstrates Association of a PER3 Polymorphism with Morningness–Eveningness Preference and Circadian Rhythm Sleep Disorder

    Akiko Hida;Shingo Kitamura;Yasuko Katayose;Mie Kato

  • Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.

    J. J. Murtagh;M. R. Mowatt;Chii-Ming Lee;Fang-Jen Scott Lee

  • Two pedigrees of familial advanced sleep phase syndrome in Japan.

    Kohtoku Satoh;Kazuo Mishima;Yuichi Inoue;Takashi Ebisawa

  • Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.

    Taro Kishi;Kenji Sakuma;Ikuo Nomura;Yuki Matsuda

Frequent Co-Authors

Takashi Kanbayashi
Takashi Kanbayashi University of Tsukuba
Masako Okawa
Masako Okawa Shiga University of Medical Science
Nakao Iwata
Nakao Iwata Fujita Health University
Katsushi Tokunaga
Katsushi Tokunaga University of Tokyo
Kiyohisa Takahashi
Kiyohisa Takahashi Shiga University of Medical Science
Yoshiharu Kim
Yoshiharu Kim National Center of Neurology and Psychiatry
Mitsuhiro Kato
Mitsuhiro Kato Showa University
Sonia Ancoli-Israel
Sonia Ancoli-Israel University of California, San Diego
Michele Ferrara
Michele Ferrara University of L'Aquila
Mitsuru Kikuchi
Mitsuru Kikuchi Kanazawa University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Kazuo Mishima

Trending Scientists